Triple Active Antiretroviral Regimen Including Enfuvirtide Via the Biojector is Effective and Safe
For full HIV virological suppression, three fully active antiretroviral agents are required. New drug classes should be included to ensure that agents are fully active. The addition of enfuvirtide and efavirenz to the present patient’s new antiretroviral regimen ensured that two fully active agents...
Saved in:
Main Authors: | Mona Loutfy, Colin Kovacs |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2007-01-01
|
Series: | Canadian Journal of Infectious Diseases and Medical Microbiology |
Online Access: | http://dx.doi.org/10.1155/2007/423578 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Patient Care and Support Measures Overcome Reluctance to Initiate New Regimen Containing Enfuvirtide
by: Benoit Trottier
Published: (2007-01-01) -
Recognizing Cognitive and Psychiatric Changes in the Post-Highly Active Antiretroviral Therapy Era
by: Adriana Carvalhal, et al.
Published: (2012-01-01) -
Updated treatment guidelines for drug-resistant TB: how safe are clofazimine-based regimens?
by: E. Pontali, et al.
Published: (2024-11-01) -
Clinicopathological and Prognostic Characteristics of Malaysian Triple Negative Breast Cancer Patients Undergoing TAC Chemotherapy Regimen
by: Ahmad Aizat Abdul Aziz, et al.
Published: (2020-01-01) -
Research on therapeutic clinical trials including immunotherapy in triple-negative breast cancer: a bibliometric analysis
by: Qi Xu, et al.
Published: (2024-10-01)